New Delhi: The approval for Bharat Biotech’s Covaxin for use in the 2-18 years age group may take time before it is made available for people.
The Drugs Controller General of India (DCGI) is carefully examining the recommendation by the expert panel and evaluating several factors, Business Standard reported on Wednesday.
Last week, the panel had recommended the usage of Covaxin for children as young as two. The final approval for 2-18 years old is under expert opinion and evaluation.
The DCGI will hold discussions with the health minister, PMO, and Bharat Biotech before granting EUA to Covaxin, the report quoted sources as saying.
Bhubaneswar: The Odisha Human Rights Commission (OHRC) has sent notices to Secretaries of Food &…
New Delhi: Even as his recently-released horror comedy ‘Bhool Bhulaiyaa 3’ continues to mint money…
New Delhi/Bhubaneswar: After over 20 days of investigation and analysing more than 700 CCTV cameras,…
New Delhi: The Delhi High Court has closed proceedings on a petition challenging the Rajiv…
Mumbai: ‘12th Fail’ actor Vikrant Massey recently got trolled after pictures of him touching his…
Mumbai: Mumbai Police swung into action immediately after Bollywood superstar Shah Rukh Khan received a…
Dubai: The effects of global climate change are being seen in various manifestations across the globe.…
Mumbai: When criminals are idolised and used for commercial purposes, police are bound to take action.…